ArticleClinical and experimental medicine2024

Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis.

Aida Raventós et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.